1. Home
  2. JNVR vs ADXN Comparison

JNVR vs ADXN Comparison

Compare JNVR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • ADXN
  • Stock Information
  • Founded
  • JNVR 2018
  • ADXN 2002
  • Country
  • JNVR United States
  • ADXN Switzerland
  • Employees
  • JNVR N/A
  • ADXN N/A
  • Industry
  • JNVR Finance: Consumer Services
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNVR Finance
  • ADXN Health Care
  • Exchange
  • JNVR Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • JNVR N/A
  • ADXN 11.3M
  • IPO Year
  • JNVR 2023
  • ADXN N/A
  • Fundamental
  • Price
  • JNVR $0.55
  • ADXN $11.26
  • Analyst Decision
  • JNVR
  • ADXN Strong Buy
  • Analyst Count
  • JNVR 0
  • ADXN 1
  • Target Price
  • JNVR N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • JNVR 21.7K
  • ADXN 24.7K
  • Earning Date
  • JNVR 11-12-2024
  • ADXN 11-11-2024
  • Dividend Yield
  • JNVR N/A
  • ADXN N/A
  • EPS Growth
  • JNVR N/A
  • ADXN N/A
  • EPS
  • JNVR N/A
  • ADXN 0.05
  • Revenue
  • JNVR $1,786,085.00
  • ADXN $960,641.00
  • Revenue This Year
  • JNVR N/A
  • ADXN N/A
  • Revenue Next Year
  • JNVR N/A
  • ADXN N/A
  • P/E Ratio
  • JNVR N/A
  • ADXN $1.87
  • Revenue Growth
  • JNVR N/A
  • ADXN N/A
  • 52 Week Low
  • JNVR $0.42
  • ADXN $5.00
  • 52 Week High
  • JNVR $1.84
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 49.64
  • ADXN 64.36
  • Support Level
  • JNVR $0.49
  • ADXN $10.04
  • Resistance Level
  • JNVR $0.62
  • ADXN $10.81
  • Average True Range (ATR)
  • JNVR 0.06
  • ADXN 0.63
  • MACD
  • JNVR -0.00
  • ADXN 0.08
  • Stochastic Oscillator
  • JNVR 58.69
  • ADXN 86.17

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: